Cue Biopharma CUE Stock
Cue Biopharma Price Chart
Cue Biopharma CUE Financial and Trading Overview
| Cue Biopharma stock price | 26.9 USD |
| Previous Close | 28.46 USD |
| Open | 28.09 USD |
| Bid | 23.69 USD x 200 |
| Ask | 35.91 USD x 200 |
| Day's Range | 25.41 - 33 USD |
| 52 Week Range | 4.98 - 41.42 USD |
| Volume | 121.02K USD |
| Avg. Volume | 757.21K USD |
| Market Cap | 129.08M USD |
| Beta (5Y Monthly) | 2.549 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -4.53 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 115 USD |
CUE Valuation Measures
| Enterprise Value | 110.32M USD |
| Trailing P/E | N/A |
| Forward P/E | -64.020836 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 3.943556 |
| Price/Book (mrq) | 4.6294065 |
| Enterprise Value/Revenue | 3.371 |
| Enterprise Value/EBITDA | -6.074 |
Trading Information
Cue Biopharma Stock Price History
| Beta (5Y Monthly) | 2.549 |
| 52-Week Change | 41.67% |
| S&P500 52-Week Change | 22.66% |
| 52 Week High | 41.42 USD |
| 52 Week Low | 4.98 USD |
| 50-Day Moving Average | 23.93 USD |
| 200-Day Moving Average | 17 USD |
CUE Share Statistics
| Avg. Volume (3 month) | 757.21K USD |
| Avg. Daily Volume (10-Days) | 80.97K USD |
| Shares Outstanding | 4.2M |
| Float | 3.55M |
| Short Ratio | 0.23 |
| % Held by Insiders | 8.55% |
| % Held by Institutions | 17.68% |
| Shares Short | 277.69K |
| Short % of Float | 7.51% |
| Short % of Shares Outstanding | 6.85% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:30 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2025 |
| Most Recent Quarter (mrq) | March 31, 2026 |
| Next Fiscal Year End | December 31, 2026 |
Profitability
| Profit Margin | -59.64% |
| Operating Margin (ttm) | -94.31% |
| Gross Margin | -2.63% |
| EBITDA Margin | -55.48% |
Management Effectiveness
| Return on Assets (ttm) | -46.076% |
| Return on Equity (ttm) | -138.52% |
Income Statement
| Revenue (ttm) | 32.73M USD |
| Revenue Per Share (ttm) | 8.75 USD |
| Quarterly Revenue Growth (yoy) | 1250.59% |
| Gross Profit (ttm) | -862000 USD |
| EBITDA | -18162000 USD |
| Net Income Avi to Common (ttm) | -19523000 USD |
| Diluted EPS (ttm) | -4.53 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 17.44M USD |
| Total Cash Per Share (mrq) | 4.31 USD |
| Total Debt (mrq) | 3.44M USD |
| Total Debt/Equity (mrq) | 15.92 USD |
| Current Ratio (mrq) | 3.571 |
| Book Value Per Share (mrq) | 6.638 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -24457000 USD |
| Levered Free Cash Flow (ttm) | -14895250 USD |
Profile of Cue Biopharma
| Country | United States |
| State | MA |
| City | Boston |
| Address | 40 Guest Street |
| ZIP | 02135 |
| Phone | 617 949 2680 |
| Website | https://www.cuebiopharma.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 29 |
Cue Biopharma, Inc., a clinical-stage therapeutics company, focuses on developing various therapies for immunological disorders. The company's lead asset is CUE-221, an anti-IgE antibody with a dual-mechanism of action currently in Phase 2 development for allergic diseases. It also developed the Immuno-STAT platform, which targets disease-specific T cells in vivo without broad immune modulation. The company's lead autoimmune candidate is CUE-401, a bifunctional IL-2 and TGF-B program that is advancing towards Phase 1 development to regulate inflammation and drive Treg-mediated tolerance. The company was formerly known as Imagen Biopharma, Inc. and changed its name to Cue Biopharma, Inc. in October 2016. Cue Biopharma, Inc. was incorporated in 2014 and is headquartered in Boston, Massachusetts.
Q&A For Cue Biopharma Stock
What is a current CUE stock price?
Cue Biopharma CUE stock price today per share is 26.9 USD.
How to purchase Cue Biopharma stock?
You can buy CUE shares on the Tech Market Small exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Cue Biopharma?
The stock symbol or ticker of Cue Biopharma is CUE.
Which industry does the Cue Biopharma company belong to?
The Cue Biopharma industry is Biotechnology.
How many shares does Cue Biopharma have in circulation?
The max supply of Cue Biopharma shares is 4.2M.
What is Cue Biopharma Price to Earnings Ratio (PE Ratio)?
Cue Biopharma PE Ratio is now.
What was Cue Biopharma earnings per share over the trailing 12 months (TTM)?
Cue Biopharma EPS is -4.53 USD over the trailing 12 months.
Which sector does the Cue Biopharma company belong to?
The Cue Biopharma sector is Healthcare.
Cue Biopharma CUE included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
|
|
{{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
US Tech Composite
IXIC
US
|
25587.04 USD — |
-2.21
|
13.85B USD — | 25513.26 USD — | 25882.57 USD — | — - | 13.85B USD — |
|
US Tech Capital Market Composite
RCMP
US
|
146.53 USD — |
-0.75
|
— — | 144.14 USD — | 148.72 USD — | — - | — — |
|
US Tech Health Care
IXHC
US
|
1184.66 USD — |
+0.75
|
— — | 1174.72 USD — | 1192.68 USD — | — - | — — |
- {{ link.label }} {{link}}